These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9298330)

  • 21. Attention deficit hyperactivity disorder and severity of substance use: the role of comorbid psychopathology.
    Torok M; Darke S; Kaye S
    Psychol Addict Behav; 2012 Dec; 26(4):974-9. PubMed ID: 22486329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
    Regan T; Tubman J
    Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
    [No Abstract]   [Full Text] [Related]  

  • 23. Gender differences in a sample of adults with attention deficit hyperactivity disorder.
    Biederman J; Faraone SV; Spencer T; Wilens T; Mick E; Lapey KA
    Psychiatry Res; 1994 Jul; 53(1):13-29. PubMed ID: 7991729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidity in adults with attention-deficit hyperactivity disorder.
    Cumyn L; French L; Hechtman L
    Can J Psychiatry; 2009 Oct; 54(10):673-83. PubMed ID: 19835674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An epidemiological study of disorders in late childhood and adolescence--I. Age- and gender-specific prevalence.
    Cohen P; Cohen J; Kasen S; Velez CN; Hartmark C; Johnson J; Rojas M; Brook J; Streuning EL
    J Child Psychol Psychiatry; 1993 Sep; 34(6):851-67. PubMed ID: 8408371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescence.
    Disney ER; Elkins IJ; McGue M; Iacono WG
    Am J Psychiatry; 1999 Oct; 156(10):1515-21. PubMed ID: 10518160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders.
    Wilens TE; Biederman J; Mick E; Faraone SV; Spencer T
    J Nerv Ment Dis; 1997 Aug; 185(8):475-82. PubMed ID: 9284860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders.
    Biederman J; Newcorn J; Sprich S
    Am J Psychiatry; 1991 May; 148(5):564-77. PubMed ID: 2018156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Attention-deficit/hyperactivity disorder and substance abuse].
    Davids E; Gastpar M
    Psychiatr Prax; 2003 May; 30(4):182-6. PubMed ID: 12768521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
    Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?
    Flory K; Lynam DR
    Clin Child Fam Psychol Rev; 2003 Mar; 6(1):1-16. PubMed ID: 12659448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial risk analyses of attention deficit hyperactivity disorder and substance use disorders.
    Biederman J; Petty CR; Wilens TE; Fraire MG; Purcell CA; Mick E; Monuteaux MC; Faraone SV
    Am J Psychiatry; 2008 Jan; 165(1):107-15. PubMed ID: 18006872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci.
    Jain M; Palacio LG; Castellanos FX; Palacio JD; Pineda D; Restrepo MI; Muñoz JF; Lopera F; Wallis D; Berg K; Bailey-Wilson JE; Arcos-Burgos M; Muenke M
    Biol Psychiatry; 2007 Jun; 61(12):1329-39. PubMed ID: 16950213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives.
    Biederman J; Faraone SV
    Psychiatr Clin North Am; 2004 Jun; 27(2):225-32. PubMed ID: 15063995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminative validity and clinical utility of an abuse-neglect interview for adolescents with conduct and substance use problems.
    Crowley TJ; Mikulich SK; Ehlers KM; Hall SK; Whitmore EA
    Am J Psychiatry; 2003 Aug; 160(8):1461-9. PubMed ID: 12900309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The co-occurrence of attention-deficit/hyperactivity disorder and unipolar depression in children and adolescents: a meta-analytic review.
    Meinzer MC; Pettit JW; Viswesvaran C
    Clin Psychol Rev; 2014 Dec; 34(8):595-607. PubMed ID: 25455624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity between disruptive disorders and depression in referred adolescents.
    Rey JM
    Aust N Z J Psychiatry; 1994 Mar; 28(1):106-13. PubMed ID: 8067955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
    Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
    PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity.
    Armstrong TD; Costello EJ
    J Consult Clin Psychol; 2002 Dec; 70(6):1224-39. PubMed ID: 12472299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity.
    Biederman J; Wilens T; Mick E; Milberger S; Spencer TJ; Faraone SV
    Am J Psychiatry; 1995 Nov; 152(11):1652-8. PubMed ID: 7485630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.